XML 66 R56.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings per share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Numerator:        
Net loss from continuing operations, net of tax $ (5,421) $ (8,791) $ (43,515) $ (113,540)
Net loss attributable to noncontrolling interests, continuing operations 597 1,488 10,129 22,898
Net loss attributable to Bioventus Inc. Class A common stockholders, continuing operations (4,824) (7,303) (33,386) (90,642)
Net loss from discontinued operations, net of tax 0 0 0 (74,429)
Net loss attributable to noncontrolling interests, discontinued operations 0 0 0 14,937
Net loss attributable to Bioventus Inc. Class A common stockholders, discontinued operations $ 0 $ 0 $ 0 $ (59,492)
Denominator:        
Weighted-average shares of Class A common stock outstanding - basic (in shares) 65,258,427 62,824,318 64,234,922 62,494,686
Weighted-average shares of Class A common stock outstanding - diluted (in shares) 65,258,427 62,824,318 64,234,922 62,494,686
Net loss per share of Class A common stock from continuing operations, basic (in dollars per share) $ (0.07) $ (0.12) $ (0.52) $ (1.45)
Net loss per share of Class A common stock from continuing operations, diluted (in dollars per share) (0.07) (0.12) (0.52) (1.45)
Net loss per share of Class A common stock from discontinuing operations, diluted (in dollars per share) 0 0 0 (0.95)
Net loss per share of Class A common stock from discontinuing operations, basic (in dollars per share) 0 0 0 (0.95)
Net loss per share of class A common stock, basic (in dollars per share) (0.07) (0.12) (0.52) (2.40)
Net loss per share of class A common stock, diluted (in dollars per share) $ (0.07) $ (0.12) $ (0.52) $ (2.40)